HyIvy is a medtech company that has already submitted an FDA 510(k) clearance, and has over 300 hospitals, GYNs, and PT clinics on their waitlist. 150 patients have benefitted from the therapy to-date, and this round will get HyIvy into hundreds more at clinics across the San Francisco area

Every gynecologist will tell you that multiple times a day they see patients whose previous condition has left them with chronic pelvic floor disorder and pain. These women may be cancer survivors, suffering through endometriosis, have unexplained vaginismus, recovering from childbirth, or managing menopause. Most of these patients aren’t even treated, instead put through a battery of tests or go on long waitlists for pelvic floor PT.

Built out of the CEO’s own experience, the Floora device empowers patients to rehabilitate from pelvic pain at home. It simultaneously collects novel biomarker data to show objective efficacy, and allows clinicians to monitor and tweak treatment remotely. It’s reimbursed under established Remote Therapeutic Monitoring codes, providing continuous revenue to both clinics and HyIvy.